Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Making Science GroupFRA:MS7 63 Debt-to-Equity is 1.06 as of Dec. 2025, which is 68% below its 10-year median of 3.34. GuruFocus rates FRA:MS7 with a GF Score™ of 63/100 and a GF Value™ of €12.08 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 832 Media - Diversified companies, Making Science Group ranks worse than 77.88% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Making Science Group's Debt-to-Equity or its related term are showing as below:
FRA:MS7'
s Debt-to-Equity Range Over the Past 10 Years
Min: 1.06 Med: 3.34 Max: 14.69
Current: 1.06
During the past 7 years, the highest Debt-to-Equity Ratio of Making Science Group was 14.69. The lowest was 1.06. And the median was 3.34.
FRA:MS7's Debt-to-Equity is ranked worse than 77.88% of 832
companies
in the Media - Diversified industry
Industry Median: 0.26
vs FRA:MS7: 1.06
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Making Science Group Debt-to-Equity Related Terms
Making Science Group Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Making Science Group's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MS7 vs APP, OMC, TTD: Debt-to-Equity Comparison
For the Advertising Agencies subindustry, Making Science Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Making Science Group Debt-to-Equity vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Making Science Group's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Making Science Group's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Making Science Group (FRA:MS7) has a Debt-to-Equity of 1.06 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Making Science Group and its competitors. This is 68% below median its historical median of 3.34. Over the past decade, Making Science Group's Debt-to-Equity has ranged from 1.06 to 14.69. According to the industry distribution chart, Making Science Group ranks #648 out of 832 companies in the Media - Diversified industry, placing it in the top 77.9%.
Is Making Science Group's Debt-to-Equity too high?
Making Science Group's current Debt-to-Equity of 1.06 is 68% below median its 10-year median of 3.34. Over the past 10 years, this metric has ranged from a low of 1.06 to a high of 14.69. The Media - Diversified industry median Debt-to-Equity is 0.26. Making Science Group's value of 1.06 is 307.7% above this industry median. Based on the distribution chart, Making Science Group ranks #648 out of 832 companies in the Media - Diversified industry, which is in the bottom quartile relative to peers. Overall, Making Science Group has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Making Science Group's Debt-to-Equity compare to APP and OMC?
According to the Media - Diversified industry distribution chart, Making Science Group ranks #648 out of 832 companies for Debt-to-Equity. This places Making Science Group in the lower half of its industry. The industry median Debt-to-Equity is 0.26. Making Science Group's value of 1.06 is 307.7% above this benchmark. Historically, Making Science Group's own Debt-to-Equity has ranged from 1.06 to 14.69 over the past decade. While the company's 10-year median is 3.34 vs. the industry median of 0.26, Making Science Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Media - Diversified company?
The median Debt-to-Equity among Media - Diversified companies is 0.26, based on 832 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Making Science Group's current Debt-to-Equity of 1.06 is 307.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Making Science Group and its competitors. For the Media - Diversified industry, the median Debt-to-Equity is 0.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Making Science Group's current Debt-to-Equity is 1.06, which is 68% below median its own 10-year median of 3.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Making Science Group stock overvalued right now?
Based on GuruFocus' analysis, Making Science Group (FRA:MS7) is currently considered Significantly Undervalued. The stock's GF Value™ is €12.08, compared to a current price of €6.45 — trading 46.6% below its estimated fair value. The current Debt-to-Equity is 1.06, which is 68% below median its 10-year median of 3.34 and 307.7% above the Media - Diversified industry median of 0.26. Making Science Group's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Making Science Group (FRA:MS7), the current Debt-to-Equity is 1.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Making Science Group (FRA:MS7) Overvalued in 2026?
Based on GuruFocus' analysis, Making Science Group stock appears to be undervalued.
The current stock price of €6.45 is trading 46.6% below its estimated GF Value™ of €12.08.
GuruFocus considers Making Science Group to be Significantly Undervalued.
Key valuation signals for FRA:MS7:
Debt-to-Equity: 1.06 (68% below median its 10-year median of 3.34)
GF Value™: €12.08 vs. price of €6.45 (46.6% below fair value)
Industry Position: 307.7% above the Media - Diversified median (#648 of 832)
No single metric tells the full story. See the FRA:MS7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Making Science Group SA is engaged in the business of technology and marketing solutions for the e-commerce and digital transformation business. The company provides solutions in the areas of digital marketing, data analytics, e-commerce, and cloud. The company carries out its professional activity in the United States, Spain, Italy, France, and other. The company obtains its income mainly from advertising and public relations services. The business segments are: Spain; International; and E-commerce and Product. The Spain and International segments, the business lines are Media and Digital Marketing, Cloud Solutions, Software & Cybersecurity, and proprietary Adtech technology. The E-commerce and Product segment focuses on the Marketplace and E-commerce business lines.
63GF Score
Get the complete analysis for FRA:MS7
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MS7 has been successfully added to your 
